Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: Anatomic site and histology differences

Cancer Epidemiology

Volumn 33, Issue 5, 2009, Pages 337-346

  Wu, Xiao Cheng ^a   Andrews, Patricia ^a   Chen, Vivien W ^a   Groves, Frank D ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Cancer registry; Extranodal non Hodgkin lymphoma; Race

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; BRAIN CANCER; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CAUCASIAN; COLORECTAL CARCINOMA; CONTROLLED STUDY; EAR CANCER; ETHNIC DIFFERENCE; FEMALE; GROUPS BY AGE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MYCOSIS FUNGOIDES; NEGRO; NONHODGKIN LYMPHOMA; NOSE CANCER; PACIFIC ISLANDER; PERIPHERAL T CELL LYMPHOMA; PHARYNX CANCER; PRIORITY JOURNAL; SEX DIFFERENCE; SKIN LYMPHOMA; STOMACH LYMPHOMA;

ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ASIAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; OCEANIC ANCESTRY GROUP; REGISTRIES; SEER PROGRAM; YOUNG ADULT;

EID: 70649084974     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2009.09.006     Document Type: Article

References (55)

1. American Cancer Society. Cancer facts & figures 2008 (2008), American Cancer Society, Atlanta
2. Groves F.D., Linet M.S., Travis L.B., and Devesa S.S. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 92 (2000) 1240-1251
3. Hartge P., Wang S.S., Bracci P.M., Devesa S.S., and Holly E.A. Non-Hodgkin lymphoma. In: Schottenfeld D., and Fraumeni Jr. J. (Eds). Cancer epidemiology and prevention (2006), Oxford, New York 898-918
4. Zucca E., Roggero E., Bertoni F., and Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 8 (1997) 727-737
5. Surveillance, Epidemiology and End Results (SEER) Program (www.see.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Limited-Use, Nov 2008 Sub (1973-2006) - Linked To County Attributes - Total U.S., 1969-2006 Counties, National Cancer Institute, DCCPS. Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission.
6. Lopez-Guillermo A., Colomo L., Jimenez M., Bosch F., Villamor N., Arenillas L., et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 23 (2005) 2797-2804
7. Jehan Z., Siraj A.K., Abubaker J., Ruiz C., Simon R., Sultana M., et al. Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma. Oncology 75 (2008) 71-80
8. Ribeiro R.C., Fairclough D.L., Sandlund J.T., Crist W.M., Berard C.W., and Pui C.H. Extranodal primary tumor site indicates poor prognosis in childhood head and neck non-Hodgkin's lymphomas. Leukemia 5 (1991) 615-620
9. Weinberg O.K., Ma L., Seo K., Beck A.H., Pai R.K., Morales A., et al. Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin. Am J Surg Pathol 33 (2009) 591-598
10. AlShemmari S.H., Ameen R.M., and Sajnani K.P. Extranodal lymphoma: a comparative study. Hematology 13 (2008) 163-169
11. de Sanjose S., Dickie A., Alvaro T., Romagosa V., Garcia Villanueva M., Domingo-Domenech E., et al. Helicobacter pylori and malignant lymphoma in Spain. Cancer Epidemiol Biomarkers Prev 13 (2004) 944-948
12. Parsonnet J., Hansen S., Rodriguez L., Gelb A.B., Warnke R.A., Jellum E., et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330 (1994) 1267-1271
13. Catassi C., Bearzi I., and Holmes G.K. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 128 (2005) S79-S86
14. Weinstock M.A., and Gardstein B. Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality. Am J Public Health 89 (1999) 1240-1244
15. In: Ellison J.H., Wu X.C., McLaughlin C.C., Lake A., Firth R., Cormier M., et al. (Eds). Cancer in North America, 1999-2003. Volume one: incidence. (May 2006), North American Association of Central Cancer Registries, Inc., Springfield, IL
16. Harwell T.S., Miller S.H., Lemons D.L., Helgerson S.D., Gohdes D., Harwell T.S., et al. Cancer incidence in Montana: rates for American Indians exceed those for whites. Am J Prev Med 30 (2006) 493-497
17. Fritz A., Percy C., Jack A., Shanmugaratnam K., Sobin L., and Parkin D. International classification of diseases for oncology. 3rd ed. (2000), World Health Organization, Geneva, Switzerland
18. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al., editors. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute. http://seer.cancer.gove/1975_2003/ [Based on November 2005 SEER data submission, posted to the SEER web site, 2006].
19. Morton L.M., Turner J.J., Cerhan J.R., Linet M.S., Treseler P.A., Clarke C.A., et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 110 (2007) 695-708
20. In: Jaffe E., Stein H., and Vardiman J.W. (Eds). Pathology and genetics of tumours of hematopoietic and lymphoid tissues (2001), IARC Press, Lyon
21. Esteve J., Benhamou E., and Raymond L. Statistical methods in cancer research. Descriptive epidemiology vol. IV (1994), International Agency for Research on Cancer, France
22. Suarez F., Lortholary O., Hermine O., and Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 107 (2006) 3034-3044
23. Perez-Perez G.I., Olivares A.Z., Foo F.Y., Foo S., Neusy A.J., Ng C., et al. Seroprevalence of Helicobacter pylori in New York City populations originating in East Asia. J Urban Health 82 (2005) 510-516
24. McQuillan G.M., Kruszon-Moran D., Kottiri B.J., Curtin L.R., Lucas J.W., and Kington R.S. Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: data from NHANES III. 1988-1994. Am J Public Health 94 (2004) 1952-1958
25. Nguyen M.H., and Keeffe E.B. Chronic hepatitis B and hepatitis C in Asian Americans. Rev Gastroenterol Disord 3 (2003) 125-134
26. Hwang S.J., Tong M.J., Lai P.P., Ko E.S., Co R.L., Chien D., et al. Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America. J Gastroenterol Hepatol 11 (1996) 949-954
27. Valleroy L.A., MacKellar D.A., Karon J.M., Rosen D.H., McFarland W., Shehan D.A., et al. HIV prevalence and associated risks in young men who have sex with men. Young Men's Survey Study Group. JAMA 284 (2000) 198-204
28. Morales Suarez-Varela M.M., Llopis Gonzalez A., Marquina Vila A., and Bell J. Mycosis fungoides: review of epidemiological observations. Dermatology 201 (2000) 21-28
29. Burg G., Kempf W., Cozzio A., Feit J., Willemze R.S., Jaffe E., et al. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol 32 (2005) 647-674
30. Ravat F.E., Spittle M.F., and Russell-Jones R. Primary cutaneous T-cell lymphoma occurring after organ transplantation. J Am Acad Dermatol 54 (2006) 668-675
31. Perret J.L., Moussavou-Kombila J.B., Delaporte E., Coniquet S., Nguemby-Mbina C., and Normand P. Mycosis fungoides in a Gabonese patient infected with HTLV-I. Med Trop 56 (1996) 66-68
32. McMullan D.M., Radovaneevic B., Jackow C.M., Frazier O.H., and Duvic M. Cutaneous T-cell lymphoma in a cardiac transplant recipient. Tex Heart Inst J 28 (2001) 203-207
33. Morozov V.A., Syrtsev A.V., Ellerbrok H., Nikolaeva E.V., Bavykin A.S., and Pauli G. Mycosis fungoides in European Russia: no antibodies to human T cell leukemia virus type I structural proteins, but virus-like sequences in blood and saliva. Intervirology 48 (2005) 362-371
34. Morales-Suarez-Varela M.M., Olsen J., Johansen P., Kaerlev L., Guénel P., Arveux P., et al. Occupational exposures and mycosis fungoides. A European multicentre case-control study (Europe). Cancer Causes Control 16 (2005) 1253-1259
35. Hirose Y., Masaki Y., Sawaki T., Shimoyama K., Karasawa H., Kawabata H., et al. Association of Epstein-Barr virus with human immunodeficiency virus-negative peripheral T-cell lymphomas in Japan. Eur J Haematol 76 (2006) 109-118
36. Anagnostopoulos I., Hummel M., Finn T., Tiemann M., Korbjuhn P., Dimmler C., et al. Heterogeneous Epstein-Barr virus infection patterns in peripheral T cell lymphoma of the angioimmunoblastic lymphadenopathy type. Verh Dtsch Ges Pathol 76 (1992) 202-206
37. Hartge P., Devesa S.S., Grauman D., Fears T.R., Fraumeni Jr. J.F., et al. Non-Hodgkin's lymphoma and sunlight. J Natl Cancer Inst 88 (1996) 298-300
38. Besson C., Goubar A., Gabarre J., Rozenbaum W., Pialoux G., Châtelet F.P., et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98 (2001) 2339-2344
39. Kadan-Lottick N.S., Skluzacek M.C., and Gurney J.G. Decreasing incidence rates of primary central nervous system lymphoma. Cancer 95 (2002) 193-202
40. Sepkowitz K.A. AIDS-the first 20 years. N Engl J Med 344 (2001) 1764-1772
41. Shmuely H., Passaro D., Figer A., Niv Y., Pitlik S., Samra Z., et al. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol 96 (2001) 3406-3410
42. Psyrri A., Papageorgiou S., and Economopoulos T. Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management. Ann Oncol 19 (2008) 1992-1999
43. Cavanna L., Pagani R., Seghini P., Zangrandi A., and Paties C. High grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature. World J Surg Oncol 6 (2008) 35
44. Nakamura S., Matsumoto T., Ye H., Nakamura S., Suekane H., Matsumoto H., et al. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment. Cancer 107 (2006) 2770-2778
45. Iwano M., Watanabe N., Matsushima Y., Seno H., Oki K., Sakurai T., et al. Rapid development of diffuse large B-Cell lymphoma after successful eradication of Helicobacter pylori for gastric MALT lymphoma. Am J Gastroenterol 101 (2006) 2878-2883
46. Logsdon M.D., Ha C.S., Kavadi V.S., Cabanillas F., Hess M.A., and Cox J.D. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. Cancer 80 (1997) 477-488
47. Horner M. Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, et al., editors. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2006/ [Based on November 2008 SEER data submission, posted to the SEER web site, 2009].
48. Zhang B., Zong Y., He J., Zhong B., and Lin S. Primary nasopharyngeal non-Hodgkin lymphoma and its relationship with Epstein-Barr virus infection. Chin Med J 116 (2003) 913-917
49. Chien Y.C., Chen J.Y., Liu M.Y., Yang H.I., Hsu M.M., Chen C.J., et al. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 345 (2001) 1877-1882
50. Hsu W.L., Chen J.Y., Chien Y.C., Liu M.Y., You S.L., Hsu M.M., et al. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan. Cancer Epidemiol Biomarkers Prev 18 (2009) 1218-1226
51. Olson J.E., Janney C.A., Rao R.D., Cerhan J.R., Kurtin P.J., Schiff D., et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 95 (2002) 1504-1510
52. Moslehi R., Devesa S.S., Schairer C., and Fraumeni Jr. J.F. Rapidly increasing incidence of ocular non-hodgkin lymphoma. J Natl Cancer Inst 98 (2006) 936-939
53. Ferreri A.J., Dolcetti R., Du M.Q., Doglioni C., Resti A.G., Politi L.S., et al. Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol 19 (2008) 835-846
54. Ponzoni M., Ferreri A.J., Guidoboni M., Lettini A.A., Cangi M.G., Pasini E., et al. Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods. Clin Cancer Res 14 (2008) 5794-5800
55. Clarke C.A., and Glaser S.L. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 94 (2002) 2015-2023